MedPath

Cranberry product versus low dose trimethoprim in the prevention of recurrent urinary infections in older women: a double blind randomised trial of effectiveness and acceptability - Cranberry versus trimethoprim

Phase 1
Conditions
Recurrent urinary tract infections
Registration Number
EUCTR2006-001313-15-GB
Lead Sponsor
niversity of Dundee
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Female
Target Recruitment
120
Inclusion Criteria

Community dwelling older women (aged 45 years or over) with at least 2 antibiotic treated UTIs or episodes of cystitis in the previous 12 months
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Previous urological surgery, stones or anatomical abnormalities or urinary tract; urinary catheter; diabetes mellitus; immunocompromised; pyelonephritis; severe renal impairment; blood dyscrasia; symptomatic UTI at baseline; cognitive impairment precluding informed consent; resident in institutional care; on longterm antibiotic therapy; on warfarin therapy; regular cranberry consumers; unwilling to participate.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath